USPTO serial 79265810
TRAXION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 10, 2020
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with TRAXION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD, GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD, GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD, GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi WOLF GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical diagnostic reagents for scientific use; reagents for use in automated test systems; reagents for analytical tests; reagents for industrial use; reagents for use in science; reagents for laboratory use; reagents for use in molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification; reagents for use in forensic analysis; reagents for blood grouping; reagents for use in environmental testing and environmental analysis; reagents for testing water and other liquids; reagents for testing aqueous solutions; deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid; ribonucleic acid; peptide nucleic acids; locked nucleic acids; nucleic acids; oligonucleotides; oligosaccharides; proteins; peptides; chemicals, enzymes and reagents for use in genome, DNA, RNA and nucleic acid synthesis; endonucleases, polymerases, ligases, glycosylases; nucleotides, pyrimidines, purines; amino acids; saccharides; reagents for biological processing; reagents for use in nucleic acid characterisation and nucleic acid sequencing; reagents for protein identification and analysis; chemicals for use in tests to detect diseases in plant life; reagents for formation of amphipathic membranes; buffer solutions; aqueous solvents; non-aqueous solvents; isopropanol; ethanol; phenol; non-aqueous media; surfactants; silicone oils; silicone fluids; enzymes; lytic enzymes including lysozyme, lyticase and cellulose; proteases; nucleases, including RNase, DNase and restriction enzymes; chaotropes, including guanidine-HCl and guanidinium thiocyanate; detergents for industrial and scientific use; proteins for use in analytical tests; all the aforesaid other than for medical or veterinary purposes; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for use in medical and scientific research | ACTIVE | — |
| 005 | Reagents for use in automated test systems for medical or veterinary use; reagents for use in blood grouping, molecular biology, bacteriological, biotechnology and microbiological analysis, including reagents for formation of amphipathic membranes, buffer solutions, non-aqueous solvents, and surfactants, all for medical or veterinary use; reagents for medical and veterinary diagnosis and medical and veterinary research; reagents for laboratory tests for medical or veterinary purposes; nucleic acid amplification reagents for veterinary or medical use; reagents for immunoassay analysers for medical or veterinary use; reagents for testing aqueous solutions for medical or veterinary use; reagents for testing for susceptibility to allergies for medical or veterinary use; reagents for use in biological processing for medical or veterinary use; reagents for use in nucleic acid characterisation and nucleic acid sequencing for medical or veterinary use; reagents for protein identification and analysis for medical or veterinary use; reagents for formation of amphipathic membranes for medical or veterinary use; buffer solutions for medical or veterinary use; aqueous solvents for medical or veterinary use; non-aqueous solvents for medical or veterinary use; non-aqueous media for medical or veterinary use; surfactants for medical or veterinary use; silicone oils for medical or veterinary use; enzymes for medical or veterinary use; proteins for use in tests for medical or veterinary purposes; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for medical or veterinary purposes | ACTIVE | — |
| 009 | Computer software for performing and controlling the analysis of data obtained from scientific tests and experiments; software for running an e-commerce platform; software for use in analysing, transmitting and receiving data via a global communications network; software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; computer operating software; operating system software; operating software for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; sensors used in electronic scientific equipment for detecting, manipulating and analysing biological, bacteriological, chemical and biochemical matter, DNA, RNA, proteins, polynucleic acids and small molecules; scientific equipment, namely, micro-array chips for the analysis and testing of biological, bacteriological, chemical and biochemical test samples, DNA, RNA, proteins, polynucleic acids and small molecules; electronic sensing apparatus for analysing chemical, biochemical, biological, bacteriological and microbiological test samples for scientific testing services; scientific apparatus and instruments for sequencing DNA, RNA, protein and polynucleic acids; scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, supervision, life-saving and teaching apparatus and instruments, namely, apparatus for testing gas, liquids and solids, none of the aforesaid being eyewear; apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, optical or electrochemical analysis, measurement of ions, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis; apparatus for the analysis of polynucleic acid sequences, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for the analysis of nucleic and polynucleic acids, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for the analysis of proteins namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for analysis of genetic information, genomic information and proteomic information, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; diagnostic and testing apparatus for testing air quality, food, soil or water, not for medical purposes; electric and electronic monitoring apparatus and instruments, namely, electric monitors and monitor modules for monitoring electric current and electrical signals; computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; scientific apparatus and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; electrowetting-on-dielectric (EWOD) devices for the display of scientific data; scientific apparatus and instruments for automating the extraction and preparation of test samples; apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments; scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; electronic display interfaces for the display for the display of information obtained from scientific equipment; silicon chips; DNA chips; analyte detector chips for scientific research and scientific testing use; biosensor chips for scientific research and scientific testing use; cartridges for test samples and cartridges for use with concentrates and solutions in solid or liquid form for use in biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis; batteries; rechargeable batteries; chargers for batteries; power packs, namely, battery packs; computer docking stations; apparatus for connecting and charging portable digital electronic devices namely, battery packs; testing apparatus incorporating chemical or biological reagents for medical purposes, namely, apparatus for testing gas liquids and solids; reaction units containing chemical or biological reagents being laboratory equipment other than for medical use; Nanopore sensing devices; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Surgical, medical and veterinary diagnostic apparatus and instruments for the testing and analysis of DNA, RNA, and other genetic material; medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; medical and veterinary apparatus using electrowetting technology; portable medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; liquid biopsy instruments; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; diagnostic apparatus and instruments in the nature of reaction units containing chemical reagents, namely, reaction systems for medical testing purposes; medical apparatus, namely, nanopore sensing devices for medical purposes; parts and fittings for all the aforesaid goods; none of the foregoing for or related to medical devices for use with endoscopes, tissue snares, or tissue retrieval devices | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for application in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services, namely, biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis for scientific or research purposes; scientific and technological services, namely, synthesizing chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific testing purposes; scientific research for medical or veterinary purposes; scientific and technological services, namely, genome, DNA, RNA and nucleic acid, oligosaccharide, protein and peptide synthesising services for scientific research purposes; scientific and technological services, namely, synthesising chemical compounds and small molecules for scientific and technological applications; DNA and RNA and polynucleic acid sequencing services for scientific and research purposes; protein sequencing services for scientific research and scientific testing purposes; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services in the fields of chemical, biochemical, biological, bacteriological, genomic and molecular analysis, for scientific testing and scientific, medical and veterinary purposes; DNA and polynucleic acid testing services; genome sequencing services for scientific and research purposes; analysis and evaluation of data in the field of biology, chemistry, biochemistry, bacteriology, DNA and RNA for scientific testing and scientific research purposes; computerised analysis of scientific and medical research data for scientific research purposes; overseeing, monitoring and managing scientific and medical research and diagnostic experiments for scientific research purposes; overseeing, monitoring and managing the analysis and evaluation of scientific and medical research data for scientific research purposes; design of scientific experiments; analysis of data generated by scientific and medical research experiments and tests for scientific and research purposes; scientific and technology services, namely, biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific research and scientific testing purposes and for medical research; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific testing and scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific testing and scientific research purposes; provision of scientific information in the form of reports relating to scientific and medical research and diagnostic experiments, the results of scientific and medical research and diagnostic experiments, the analysis and evaluation of scientific and medical research data, and data generated by scientific and medical research and medical diagnostic experiments for scientific research purposes; scientific and medical research and development services; technical data analysis and evaluation services in the fields of scientific, medical technology and medical research; electronic data storage services; application service provider (ASP) services featuring computer software applications for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices for the analysis of scientific data; computerised analysis of medical research data, namely, the results of scientific tests and experiments for medical research purposes; overseeing, monitoring and managing medical research tests for medical research purposes; overseeing, monitoring and managing the analysis and evaluation of medical research data for medical research purposes; scientific and technological services, namely, biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for medical research purposes; provision of scientific information in the form of reports relating to the results of medical research tests, the analysis and evaluation of medical research data, and data generated by medical research tests, none being for medical treatment or diagnostic purposes; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named TRAXION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 14, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 18, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 18, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 10, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 10, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 25, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 25, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 29, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 29, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 29, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 12, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 12, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 12, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 12, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 12, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Feb 10, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jan 31, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 26, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 10, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Sep 11, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 10, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 31, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |